Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 30, 2018

View Archived Issues

Patient enrollment ongoing in first-in-human trial of PF-06939926

Sun Biopharma initiates first-line combination study of SBP-101 with gemcitabine and nab-paclitaxel

FDA gives fast track status to Ensysce's PF-614

Zika virus vaccine candidate from Takeda obtains FDA fast track designation

Trial results support safety and activity of carotuximab + sorafenib in hepatocellular carcinoma

ASPH marker possibly useful for CRC screening

EMA committee recommends approval of Lamzede for alpha-mannosidosis

United Neuroscience to develop vaccine to prevent chronic traumatic encephalopathy

GSK-2256098/trametinib combination lacks activity in phase II PDAC study

Innate Pharma and MedImmune collaborate to study IPH-5401 with durvalumab

Chinese authorities approve clinical trials of ZKAB-001

First patient with DLBCL enrolled in phase II study of Cellectar's CLR-131

FDA awards RMAT designation to Abeona Therapeutics' EB-101

Regeneron studies long-term safety and efficacy of evinacumab in patients with HoFH

BL-8040 therapy impacts immune cell populations in pancreatic cancer patients

FDA issues complete response letter for Linhaliq NDA

Pfizer files for approval of lorlatinib in Japan

Bristol-Myers Squibb presents novel ROCK inhibitors

Leo Pharma divulges RORG ligands for psoriasis

Almac Discovery discloses new Wee1 inhibitors

Duke University patents APC-containing vaccines for cancer

Ibentrus identifies new fusion proteins for cancer

ProMetic Life Sciences finalizes design of phase III study of PBI-4050 in IPF

FDA accepts revefenacin NDA

Johnson & Johnson reviews pipeline progress of fourth quarter 2017

Phase I data presented for JCAR-017 in B-NHL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...